- Home
- NXDT vs CDXS Comparison
NXDT vs CDXS Comparison
Compare NXDT & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXDT
- CDXS
- Stock Information
- Founded
- NXDT 2012
- CDXS 2002
- Country
- NXDT United States
- CDXS United States
- Employees
- NXDT N/A
- CDXS N/A
- Industry
- NXDT Investment Managers
- CDXS Major Chemicals
- Sector
- NXDT Finance
- CDXS Industrials
- Exchange
- NXDT Nasdaq
- CDXS Nasdaq
- Market Cap
- NXDT 223.1M
- CDXS 216.6M
- IPO Year
- NXDT N/A
- CDXS 2010
- Fundamental
- Price
- NXDT $3.52
- CDXS $2.64
- Analyst Decision
- NXDT
- CDXS Buy
- Analyst Count
- NXDT 0
- CDXS 2
- Target Price
- NXDT N/A
- CDXS $11.00
- AVG Volume (30 Days)
- NXDT 133.6K
- CDXS 517.3K
- Earning Date
- NXDT 01-01-0001
- CDXS 10-30-2025
- Dividend Yield
- NXDT 9.66%
- CDXS N/A
- EPS Growth
- NXDT N/A
- CDXS N/A
- EPS
- NXDT 0.99
- CDXS N/A
- Revenue
- NXDT N/A
- CDXS $57,164,000.00
- Revenue This Year
- NXDT N/A
- CDXS $12.88
- Revenue Next Year
- NXDT N/A
- CDXS $21.64
- P/E Ratio
- NXDT $6.41
- CDXS N/A
- Revenue Growth
- NXDT N/A
- CDXS N/A
- 52 Week Low
- NXDT $5.89
- CDXS $1.90
- 52 Week High
- NXDT $13.07
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- NXDT 32.42
- CDXS 52.60
- Support Level
- NXDT $3.38
- CDXS $2.51
- Resistance Level
- NXDT $4.04
- CDXS $2.73
- Average True Range (ATR)
- NXDT 0.16
- CDXS 0.11
- MACD
- NXDT -0.04
- CDXS 0.03
- Stochastic Oscillator
- NXDT 7.06
- CDXS 56.80
About NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.